Morgan Stanley’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.4M Sell
3,603,068
-756,684
-17% -$11.6M ﹤0.01% 2092
2026
Q1
$61.6M Buy
4,359,752
+114,950
+3% +$1.69M ﹤0.01% 1890
2025
Q4
$60.1M Sell
4,244,802
-239,913
-5% -$3.47M ﹤0.01% 1913
2025
Q3
$66.3M Buy
4,484,715
+672,781
+18% +$10.1M ﹤0.01% 1771
2025
Q2
$57.7M Sell
3,811,934
-368,877
-9% -$5.39M ﹤0.01% 1795
2025
Q1
$60.2M Sell
4,180,811
-123,494
-3% -$1.89M ﹤0.01% 1650
2024
Q4
$65.2M Sell
4,304,305
-66,353
-2% -$1.07M ﹤0.01% 1588
2024
Q3
$71.9M Sell
4,370,658
-1,231,401
-22% -$20.2M 0.01% 1509
2024
Q2
$91.9M Sell
5,602,059
-436,016
-7% -$7.01M 0.01% 1237
2024
Q1
$101M Sell
6,038,075
-9,094,925
-60% -$141M 0.01% 1188
2023
Q4
$226M Buy
15,133,000
+5,373,782
+55% +$78.1M 0.01% 1078
2023
Q3
$141M Sell
9,759,218
-146,445
-1% -$2.19M 0.01% 862
2023
Q2
$151M Sell
9,905,663
-285,384
-3% -$4.29M 0.01% 845
2023
Q1
$154M Buy
10,191,047
+398,815
+4% +$5.91M 0.02% 808
2022
Q4
$136M Buy
9,792,232
+1,402,023
+17% +$19.8M 0.02% 857
2022
Q3
$114M Buy
8,390,209
+1,016,911
+14% +$15.1M 0.02% 815
2022
Q2
$108M Buy
7,373,298
+2,377,467
+48% +$36.7M 0.01% 879
2022
Q1
$82.7M Buy
4,995,831
+418,060
+9% +$7.34M 0.01% 990
2021
Q4
$89M Sell
4,577,771
-75,582
-2% -$1.47M 0.01% 972
2021
Q3
$94M Buy
4,653,353
+698
+0% +$15.1K 0.01% 875
2021
Q2
$102M Buy
4,652,655
+855,847
+23% +$18.2M 0.01% 834
2021
Q1
$77.9M Buy
3,796,808
+1,732,478
+84% +$37.5M 0.01% 902
2020
Q4
$44.9M Buy
2,064,330
+1,475,123
+250% +$31.2M 0.01% 1170
2020
Q3
$12.1M Buy
+589,207
New +$11.9M ﹤0.01% 1877

Other funds holding BCAT

Morgan Stanley's BCAT Position: Q2 2026 in Review

Morgan Stanley reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 17% in Q2 2026, selling an estimated $11.6M and leaving 3,603,068 shares worth $57.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Morgan Stanley first reported a position in BCAT in Q3 2020 and has held it in 24 quarters since. The position peaked at $226M in Q4 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Morgan Stanley held 3,603,068 shares of BlackRock Capital Allocation Term Trust worth $57.4M as of Q2 2026.
  • Morgan Stanley sold 756,684 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $11.6M.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2092 holding.
  • Morgan Stanley first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's BlackRock Capital Allocation Term Trust position peaked at $226M in Q4 2023.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.